Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)
This study has been completed.
Study NCT00156013 Information provided by Oncology Specialists, S.C.
First Received on September 8, 2005. Last Updated on June 4, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Immune System Diseases
Neoplasms by Histologic Type
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Oncology Specialists, S.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers